A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...

The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.

Started by a patient, HealthTree lets blood cancer patients look for clinical trials and treatment options, share their data with researchers.

All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Breast cancer remains a global challenge, marked by diverse patient responses to treatments and varying prognoses. The ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines mark a significant milestone in breast cancer treatment, seamlessly integrating cutting-edge international research with Chinese ...

Nurses and APPs provide an essential link between physicians and patients when facilitating and monitoring outcomes with personalized cancer vaccines.